**11. References**

Akdis C., Bieber T., Akdis M., et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allerogology PRACTALL Consensus Report. *J* 

Clinical Management of Atopic Dermatitis 265

Graves J, Nunley K, Heffernan M. Off-label uses of biologics in dermatology: rituximab,

Grupper C. The chemistry, pharmacology and use of tar in treatment of psoriasis. In: Farber

Hanifin J, Schneider L, Leung D, et al. Recombinant interferon gamma therapy for atopic

Hennekes H and Asadullah K. Strategies for Targeting IL-4 as a Novel Therapeutic

Hon K, Ching G, Leung T, et al. Efficacy and tolerability at 3 and 6 months following use of

Kang S, Lucky A, Pariser D, et al. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. *J Am Acad Dermatol.* 2001;44:S58-S64. Klein P, Clark R. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. *Arch Dermatol.* 1999;135:1522–1525. (Ia) Kodama A, Horikawa T, Suzuki T, et al. Effect of stress on atopic dermatitis: investigation in patients after the great hanshin earthquake. *J Allergy Clin Immunol.* 1999;104:173–176.

Koopman L, van Strien R, Kerkhof M, et al. Placebo-controlled trial of house dust mite-

Kristal L, Klein P. Atopic dermatitis in infants and children. *Pediatr Clin North Am.* 2000;47:

Lavker R, Grove F, Kligman A. The atrophogenic effect of crude coal tar on human

Leung A, Barber K. Managing Childhood Atopic Dermatitis. *Adv Dermatol*. 2003; 20: 129-137. Leung A, Wong B, Chan P, et al. Pruritus in children. *J R Soc Health.* 1998;118:280-286. Leung D, Eichenfield LF, Boguniewicz M. Atopic dermatitis (atopic eczema). In: Freeberg

Leung D, Nicklas R, Li J. et al. Disease management of atopic dermatitis: an updated

Lipozencic J. The diagnostic value of atopy patch testing and prick testing in atopic

Lipozencic J, Wolf R. Atopic Dermatitis: an Update and Review of the Literature. *Dermatol* 

Melin L, Frederiksen T, Noren P, et al. Behavioural treatment of scratching in patients with

Michel S, Yawalkar N, Schnyder B, et al. Eczematous skin reaction to atopy patch testing

with cockroach in patients with atopic dermatitis. *J Investig Allergol Clin Immunol*

of 2). *J Am Acad Dermatol* 2007; 56:e55.

Habif, T. 2008. *Clinical Dermatology.* Mosby, 978-0-7234-3541-9. Britain.

dermatitis. *J Am Acad Dermatol* 1993; 28:189.

*Inflammatory & Anti-Allergy Agents*, 2002, 1, 41-53

Stanford University, 1971: 347–56.

*Dermatol Treat* 2009; 20:141.

*Crit Care Med* 2002;166(3):307–13.

McGraw-Hill, 2003:1464–1480.

*Clin* 2007; 25: 605–612

2009;19(3):173–9.

*Immunol*. 2004 Sep;93(3 Suppl 2):S1-21.

dermatitis. *Clin Dermatol* 2010:28:38-44.

atopic dermatitis. *Br J Dermatol.* 1986;115:467–474.

epidermis. *Br J Dermatol* 1981; 105: 77–81. Leung A, Hon K. Atopic Dermatitis. *Adv Pediatr* 2007;54:241-273.

877-895.

omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (part 2

EM, Cox AJ, eds. Psoriasis: Proceeding of International Symposium. Stanford:

Approach for theTreatment of Atopic Dermatitis. *Curr. Med. Chem. – Anti-*

azathioprine for recalcitrant atopic dermatitis in children and young adults. *J* 

impermeable mattress covers: effect on symptoms in early childhood. *Am J Respir* 

IM, Eisen AZ, et al., eds. Dermatology in General Medicine, 6th ed. New York:

practice parameter. Joint Task Force on Practice Parameters. *Ann Allergy Asthma* 

*Allergy Clin Immunol* 2006:118:152-169. Andersen P, Bindslev-Jensen C, Mosbech H, et al. Skin Symptoms in Patients with Atopic Dermatitis Using Enzyme-containing Detergents. A Placebo-controlled Study*. Acta Derm Venereol*. 1998; 78: 60–62


Detergents. A Placebo-controlled Study*. Acta Derm Venereol*. 1998; 78: 60–62

Arlian L, Platts-Mills T. The biology of dust mites and the remediation of mite allergens in

Baumer W, Hoppmann J, Rundfeldt C, et al. Highly selective phosphodiesterase 4 inhibitors

Bekersky I, Fitzsimmons W, Tanase A, et al. Nonclinical and early clinical development of

Bender B. Psychological dysfunction associated with atopic dermatitis. *Immunol Allergy Clin* 

Bettrani V. The clinical spectrum of atopic dermatitis. *J Allergy Clin Immunol* 2007;104 (Suppl

Bieber, T. 2008. Mechanisms of Disease Atopic Dermatitis. *New England Journal of Medicine,* 

Bleehen SS, Chu AC, Hamann I, et al. Fluticasone propionate 0.05% cream in the treatment

Bornhovd E, Burgdorf W, Wollenberg A: Immunomodulatory macrolactams for topical

Brazzelli V, Prestinari F, Chiesa M, et al. Sequential treatment of severe atopic dermatitis

Callard R, Harper J. The Skin Barrier, Atopic Dermatitis and Allergy: A Role for Langerhans

Callen J, Chamlin, S, Eichenfield, L, et al. A systematic review of the safety of topical

Clinical Trials. Preliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in

Correale C, Walker C, Murphy L, et al. Atopic dermatitis: a review of diagnosis and

Caubet, J, Eigenmann, P. 2010. Allergic Triggers in Atopic Dermatitis. *Immunology Allergy* 

Fleischer A Jr. Treatment of atopic dermatitis: role of tacrolimus ointment as a topical noncorticosteroid therapy. *J Allergy Clin Immunol.* 1999;104:S126-S130. Ghazvini, P, Pagan L, Rutledge T, Goodman, S. 2010. *Journal of Pharmacy Practice,* 23,2, 110-116. Grassberger M, Baumruker T, Enz A, et al. A novel anti-infl ammatory drug, SDZ ASM 981,

for the treatment of skin diseases: in vitro pharmacology. *Br J Dermatol* 1999; 141:

therapies for atopic dermatitis. *Br J Dermatol*. 2007;156: 203–221.

of atopic eczema: a multicentre study comparing once-daily treatment andoncedaily vehicle cream application versus twice-daily treatment. Br J Dermatol.

treatment of infl ammatory skin diseases. *Curr Opin Investig Drugs* 2002; 3: 708–712.

with cyclosporin A and low-dose narrow-band UVB phototherapy. *Dermatol* 2002;

Atopic Dermatitis (Eczema). Accessed 5/11/11. Available from:

allergic disease. *J Allergy Clin Immunol.* 2001;107(Suppl):S406–S413.

Andrew N, Moses K. Tar revisited. Int J Dermatol 1985; 24: 216–8.

*Targets.* 2007 Mar;6(1):17-26.

*North Am.* 2002; 22:43–53.

2001;44:S17-S27.

358,14, 1483-1494.

1995;133(4):592-597.

www.clinicaltrials.gov

*Clinics North America,* 30, 289-307.

Deshazo R. Atopic dermatitis. *Am J Med* 2009;122-121-125.

Cells? *Trends Immunol.* 2007. Jul;28(7):294-8.

treatment. *Am Fam Physician.* 1999;60:1191-1198.

Denman S. A review of pruritus. *J Am Acad Dermatol.* 1986;14:375-392.

2):S87-S98.

204:252.

264–273.

*Allergy Clin Immunol* 2006:118:152-169. Andersen P, Bindslev-Jensen C, Mosbech H, et al. Skin Symptoms in Patients with Atopic Dermatitis Using Enzyme-containing

for the treatment of allergic skin diseases and psoriasis. *Inflamm Allergy Drug* 

tacrolimus ointment for the treatment of atopic dermatitis. *J Am Acad Dermatol.* 


**Part 4** 

**New Treatments** 

